Marex (MRX)

Market Price (9/18/2026): $73.26 | Market Cap: $5.3 BilSector: Financials | Industry: Diversified Capital Markets

Marex (MRX)

Market Price (9/18/2026): $73.26
Market Cap: $5.3 Bil
Sector: Financials
Industry: Diversified Capital Markets

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.9%

Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 49%

Megatrend and thematic drivers
Megatrends include Capital Markets Modernization. Themes include Algorithmic Trading & Market Making, Global Commodity & Energy Market Access, and Financial Market Infrastructure Platforms.

Weak multi-year price returns
2Y Excs Rtn is -24%, 3Y Excs Rtn is -59%

Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 60%

Key risks
MRX key risks include [1] significant legal and regulatory scrutiny stemming from allegations of a multi-year accounting fraud, Show more.

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.9%
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 49%
2	Megatrend and thematic drivers Megatrends include Capital Markets Modernization. Themes include Algorithmic Trading & Market Making, Global Commodity & Energy Market Access, and Financial Market Infrastructure Platforms.
3	Weak multi-year price returns 2Y Excs Rtn is -24%, 3Y Excs Rtn is -59%
4	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 60%
5	Key risks MRX key risks include [1] significant legal and regulatory scrutiny stemming from allegations of a multi-year accounting fraud, Show more.

MRX in ETFs

Weight = MRX's share of each fund

IWM0.15%

IWO0.23%

VTWO0.13%

IWN0.08%

DFAS0.01%

IWV0.01%

DFAC0.00%

Valuation & Metrics

FYE: 12/31	Forward FYE		Now	Historical (CYE & TTM)
	2027	2026	9/18/26	2025	2024	2023	2022
Share Price			$73.26	$38.36	$31.17	�	�
Mkt Cap ($ Bil)			5.3	2.4	1.8	-	-
+ Debt ($ Bil)			11.5	10.2	6.1	5.4	0.0
- Cash ($ Bil)			8.4	6.5	5.1	4.7	0.0
TEV ($ Bil)			8.4	12.6	7.9
Valuation Ratios
P/S	1.8	1.9	1.0	0.6	0.6	-	-
P/EBIT	7.6	8.5	3.0	1.8	1.8	-	-
P/E	10.3	11.5	12.4	7.7	8.1	-	-
P/FCF	—	—	-	-	-	-	-
Sector Ratios (* = sector average)
P/S *			3.3	3.0	3.1	2.8	2.8
P/EBIT *			6.9	7.7	8.5	7.7	7.2
P/E *			11.6	11.0	11.6	10.1	9.4
P/FCF *			8.8	9.0	9.0	8.0	6.4

FYE: 12/31	Forward FYE		Now
	2027	2026	9/18/26
Share Price			$73.26
Mkt Cap ($ Bil)			5.3
+ Debt ($ Bil)			11.5
- Cash ($ Bil)			8.4
TEV ($ Bil)			8.4
Valuation Ratios
P/S	1.8	1.9	1.0
P/EBIT	7.6	8.5	3.0
P/E	10.3	11.5	12.4
P/FCF	—	—	-
Sector Ratios (* = sector average)
P/S *			3.3
P/EBIT *			6.9
P/E *			11.6
P/FCF *			8.8

FYE: 12/31	MRX [1]	S&P 500 [2]
REVENUE GROWTH
LTM Revenue [3]	$5.2 Bil	—
FY 2026 Sales	$2.7 Bil	—
FY 2027 Sales	$3.0 Bil	—
FY 2026 Sales Growth	-47.5%	—
FY 2027 Sales Growth	10.1%	12.8%
EARNINGS
LTM Net Income (GAAP) [3]	$426.0 Mil	—
FY 2026 Net Income (Non-GAAP)	$459.2 Mil	—
FY 2027 Net Income (Non-GAAP)	$514.2 Mil	—
FY 2027 Net Income Growth	12.0%	18.1%
FY 2026 EPS (Non-GAAP)	$6.03	—
FY 2027 EPS (Non-GAAP)	$6.75	—
FY 2027 EPS Growth	12.0%	—
VALUATION
FY 2026 P/S	1.9	1.6
FY 2027 P/S	1.8	—
FY 2026 P/E	11.5	7.5
FY 2027 P/E	10.3	—

[1] MRX forward figures are analyst consensus for the next two fiscal years (fiscal year end 12/31). Net Income and EPS are non-GAAP (adjusted) consensus. P/S and P/E divide the current market cap by the consensus figure.
[2] S&P 500 figures are the SPY ETF's holdings-weighted forward aggregate. P/S and P/E reflect FY1/FY2 consensus blended to the 12-month window ending 9/30/27 (~one year forward), shown when ≥90% of index weight has estimates. Growth is the aggregate next-fiscal-year vs current-fiscal-year (FY1→FY2) change. Index-level dollar Sales, Net Income and EPS are not applicable.
[3] LTM = reported trailing-twelve-month actuals (GAAP).

	MRX	S&P 500
REVENUE GROWTH	VERY GOOD
Rev LTM ($ Bil)	5.2
Rev Chg Q	135.3%	9.1%
Rev Chg LTM	48.9%	8.3%
Rev Chg 3Y Avg	35.9%	5.8%
PROFITABILITY	GOOD
Op Inc LTM ($ Bil)	1.8
CFO LTM ($ Bil)	�
Net Inc LTM ($ Bil)	0.4
Op Mgn LTM	33.9%	18.6%
Net Inc Mgn	8.2%	13.1%
VALUATION	LOW
P/S	1.0	3.1
P/E	12.4	22.5

AI Analysis | Feedback

Metric	Value	Date	Source
Average Number of Employees	3619	12312023	Link

Price Chart

No Events

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 9/14/2026

Marex (MRX) stock has gained about 15% since it went public on 7/1/2026 because of the following key factors:

1. Exceptional Fiscal Q2 2026 Earnings Exceeded Expectations and Drove Stock Surge.

Marex Group Limited (MRX) reported robust financial results for fiscal Q2 2026, which ended on June 30, 2026, and were announced on August 12, 2026. The company posted earnings per share (EPS) of $1.64, significantly beating analysts' consensus estimates of $1.36 by 20.59%. Revenue for the quarter surged 39% year-on-year to $695.8 million, while Adjusted Profit Before Tax (PBT) increased by 56% to $165.9 million. This strong performance, which also saw basic EPS grow 103% to $2.09, led to an over 18% stock price increase on August 12, 2026.

2. Strategic Acquisitions Expanded Market Reach and Bolstered Growth Prospects.

During the period, Marex actively pursued a growth-by-acquisition strategy. On July 9, 2026, Marex announced its agreement to acquire Bright Point International, a clearing business intended to expand its exposure to Asian markets and provide access to markets in China. This was followed by the completion of the acquisition of Webb Traders, an equity derivatives market maker, on August 3, 2026. Further strengthening its position, Marex agreed to acquire Brainchild Capital Investments on August 10, 2026, gaining access to derivatives and physical markets in power and gas. These strategic moves fueled significant year-over-year segment revenue growth, particularly a 134% increase in Market Making and a 35% increase in Agency and Execution, as reported for the first half of fiscal year 2026.

3. Favorable Analyst Sentiment and Price Target Revisions Supported Momentum.

Marex Group plc consistently received a consensus "Buy" rating from various research firms during this period. Several analysts upgraded their price targets in July and August 2026. For example, Piper Sandler increased its target price from $55.00 to $75.00 on July 15, 2026, and Compass Point set an $80.00 price target on July 9, 2026. Goldman Sachs Group also reissued a "buy" rating with an $80.00 price objective on August 14, 2026. This positive analyst coverage and upward revision in price targets contributed to investor confidence and the stock's upward trend.

4. Significant Insider Buying Signaled Confidence.

Over the last three months, insiders demonstrated strong confidence in Marex, with reported buying activity totaling $256.5 million, representing 4.7 million shares. This substantial insider buying significantly outweighs insider selling during the same period, which amounted to $5.1 million for 94.4K shares, much of which was likely for tax withholding or pre-planned dispositions. The overwhelming insider buying activity underscored a strong belief in the company's future prospects and valuation.

Show less

Holding a concentrated position? Know your true downside before the momentum shifts.

Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

null
null

Market Drivers

5/31/2026 to 9/17/2026

	Return	Correlation
MRX
Market (SPY)	0.8%	28.2%
Sector (XLF)	8.3%	11.6%

Fundamental Drivers

null
null

Market Drivers

2/28/2026 to 9/17/2026

	Return	Correlation
MRX
Market (SPY)	11.5%	28.2%
Sector (XLF)	9.2%	11.6%

Fundamental Drivers

null
null

Market Drivers

8/31/2025 to 9/17/2026

	Return	Correlation
MRX
Market (SPY)	19.2%	28.2%
Sector (XLF)	4.7%	11.6%

Fundamental Drivers

null
null

Market Drivers

8/31/2023 to 9/17/2026

	Return	Correlation
MRX
Market (SPY)	75.3%	28.2%
Sector (XLF)	69.8%	11.6%

Return vs. Risk

Price Returns Compared

	2021	2022	2023	2024	2025	2026	Total [1]
Returns
MRX Return	-	-	-	-	-	11%	11%
Peers Return	55%	36%	6%	44%	3%	-12%	190%
S&P 500 Return	27%	-19%	24%	23%	16%	10%	101%
Monthly Win Rates [3]
MRX Win Rate	-	-	-	-	-	33%
Peers Win Rate	75%	67%	67%	75%	46%	49%
S&P 500 Win Rate	75%	42%	67%	75%	67%	44%
Max Drawdowns [4]
MRX Max Drawdown	-	-	-	-	-	-
Peers Max Drawdown	-18%	-25%	-29%	-33%	-26%	-43%
S&P 500 Max Drawdown	-5%	-25%	-10%	-8%	-19%	-9%

[1] Cumulative total returns since the beginning of 2021
[2] Peers: IOND, PWCM, VIP, LPLA, CRCL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 9/17/2026 (YTD)

MRX has limited trading history. Below is the Financials sector ETF (XLF) in its place.

Event	XLF	S&P 500
2025 US Tariff Shock
% Loss	-15.5%	-18.8%
% Gain to Breakeven	18.4%	23.1%
Time to Breakeven	80 days	79 days
Summer-Fall 2023 Five Percent Yield Shock
% Loss	-10.7%	-9.5%
% Gain to Breakeven	12.0%	10.5%
Time to Breakeven	26 days	24 days
2023 SVB Regional Banking Crisis
% Loss	-16.1%	-6.7%
% Gain to Breakeven	19.1%	7.1%
Time to Breakeven	270 days	31 days
2022 Inflation Shock & Fed Tightening
% Loss	-22.3%	-24.5%
% Gain to Breakeven	28.6%	32.4%
Time to Breakeven	467 days	427 days
2020 COVID-19 Crash
% Loss	-42.8%	-33.7%
% Gain to Breakeven	74.8%	50.9%
Time to Breakeven	289 days	140 days
Q4 2018 Fed Policy Error / Growth Scare
% Loss	-19.7%	-19.2%
% Gain to Breakeven	24.5%	23.8%
Time to Breakeven	123 days	105 days

Compare to IOND, PWCM, VIP, LPLA, CRCL

In The Past

State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

MRX has limited trading history. Below is the Financials sector ETF (XLF) in its place.

Event	XLF	S&P 500
2022 Inflation Shock & Fed Tightening
% Loss	-22.3%	-24.5%
% Gain to Breakeven	28.6%	32.4%
Time to Breakeven	467 days	427 days
2020 COVID-19 Crash
% Loss	-42.8%	-33.7%
% Gain to Breakeven	74.8%	50.9%
Time to Breakeven	289 days	140 days
2015-2016 China Devaluation / Global Growth Scare
% Loss	-21.4%	-12.2%
% Gain to Breakeven	27.3%	13.9%
Time to Breakeven	272 days	62 days
2011 US Debt Ceiling Crisis & European Contagion
% Loss	-26.1%	-17.9%
% Gain to Breakeven	35.3%	21.8%
Time to Breakeven	162 days	123 days
2008-2009 Global Financial Crisis
% Loss	-78.3%	-53.4%
% Gain to Breakeven	359.8%	114.4%
Time to Breakeven	2329 days	1085 days

Compare to IOND, PWCM, VIP, LPLA, CRCL

In The Past

State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Marex (MRX)

Business Description Analogies Products Customers Suppliers Management Key Risks Emerging Threats Market Size Revenue Drivers Capital Allocation

Marex (MRX) is a global financial services platform that provides essential liquidity, market access, and infrastructure services across energy, commodities, and financial markets. The company acts as a critical intermediary, connecting its diverse client base, which includes commodity producers, consumers, banks, asset managers, and wholesale counterparties, to 58 global exchanges. Operating primarily in Europe, the Americas, and with a growing presence in the Middle East and Asia-Pacific, Marex thrives in a complex market characterized by high barriers to entry and reduced competitive intensity from traditional large financial institutions.

Marex offers a comprehensive suite of services organized into four key segments. Its central "Clearing" business provides connectivity to global exchanges, enabling clients to trade and generating commission and interest income. Through "Agency and Execution," Marex facilitates price discovery and matches buyers and sellers for both listed and over-the-counter products. The "Market Making" segment provides direct market pricing by acting as principal with conservatively managed risk. Lastly, "Hedging and Investment Solutions" offers bespoke hedging strategies for commodity and currency exposure, alongside structured financial products for investors. These integrated services are supported by Marex's advanced technology and deep market expertise, fostering strong client relationships and cross-selling opportunities.

AI Analysis | Feedback

Here are 1-3 brief analogies for Marex (MRX):

Marex is like a specialized, global prime broker for commodities and derivatives.
Marex is an institutional version of Interactive Brokers or a B2B Fidelity, specializing in energy and commodities trading and clearing.

AI Analysis | Feedback

Marex (MRX) provides the following major services:

Clearing: Connects clients to global exchanges and central clearing houses, acting as principal and earning commissions per trade.
Agency and Execution: Facilitates price discovery by matching buyers and sellers on an agency basis across various commodity and financial markets, generating commissions.
Market Making: Provides direct market pricing to professional counterparties as principal in commodity and securities markets, earning revenue through spreads.
Hedging and Investment Solutions: Offers bespoke hedging solutions for commodity and exchange rate exposure, along with structured financial products for investor market access.

AI Analysis | Feedback

Marex (MRX) primarily serves other companies rather than individuals. The provided background information does not list specific names of its customer companies or their public symbols. However, the company description clearly identifies the following categories of major customers:

Traditional consumers of commodities
Traditional producers of commodities
Financial clients, such as banks and asset managers

AI Analysis | Feedback

Hong Kong Exchanges and Clearing Limited (HKEX)

CME Group Inc. (CME)

Intercontinental Exchange (ICE)

AI Analysis | Feedback

Ian Lowitt, Group Chief Executive Officer

Ian Lowitt was appointed Chief Executive Officer in January 2016 and a Director in November 2012. Prior to Marex, he served as COO of Barclays Wealth America, managing the integration of Lehman Brothers' businesses and support functions after Barclays' acquisition. He spent 14 years at Lehman Brothers, holding roles such as Chief Financial Officer and Co-Chief Administrative Officer, and was the firm's last CFO before its 2008 collapse. Lowitt also served as Head of Strategy, Global Treasurer, Head of Tax, and European Chief Administrative Officer at Lehman Brothers. Marex's ownership was significantly shaped by the acquisition of a 74% stake by the hedge fund JRJ Group in 2010, which appointed former Lehman Brothers bankers to its board.

Rob Irvin, Group Chief Financial Officer

Rob Irvin became Chief Financial Officer in April 2023 and was appointed as a Director in May 2023. He joined Marex after a decade at HSBC, where his roles included Global CFO for HSBC's Private Bank and, previously, CFO of HSBC's Investment Bank. Irvin is a chartered accountant and previously worked in Deloitte's transaction services division, focusing on financial and operational due diligence for major capital markets transactions.

Paolo Tonucci, Chief Strategist and CEO, Capital Markets

Paolo Tonucci joined Marex in 2018 as COO, becoming CFO in 2020, and then transitioning to his current role as Chief Strategist and CEO of Capital Markets in April 2023. Prior to Marex, he was Group Treasurer at Commonwealth Bank of Australia and Head of Funding and Liquidity at Barclays Bank in London. He also spent 12 years as Global Treasurer for Lehman Brothers. M&A has played a significant role in Marex's growth under his leadership in Capital Markets and strategy.

Simon van den Born, President

Simon van den Born serves as the President of Marex.

Arthur Fan, CEO, APAC

Arthur Fan is the CEO of Marex's APAC region.

AI Analysis | Feedback

Regulatory, Compliance, and Technological Risks: Marex operates in a highly regulated and technologically complex financial services market, facing significant infrastructure requirements and ongoing regulatory scrutiny across multiple jurisdictions. The company explicitly states the need to "ensure regulatory compliance through our enterprise risk management framework." Failure to comply with evolving regulations, maintain robust technological infrastructure, or protect against cyber threats could lead to significant penalties, operational disruptions, and reputational damage.
Financial Market and Credit Risks: As a diversified global financial services platform, Marex is inherently exposed to financial market fluctuations and client credit risk. In its Clearing business, it holds collateral to manage "client credit risk," and insufficient collateral or client defaults could pose a risk. In Market Making, while risks are managed conservatively, adverse market movements could still impact profitability. Furthermore, the Hedging and Investment Solutions segment involves holding principal balances of issued notes on its balance sheet, which introduces balance sheet risk related to market movements or underlying asset performance.
Competition: Despite a reported decline in competitive intensity in some segments (e.g., the number of Futures Commission Merchants has decreased), Marex operates in competitive markets across its segments. It competes against other independent non-bank FCMs and large global investment banks in Clearing, against various brokerage firms in Agency and Execution, against other financial institutions in Market Making, and against financial firms and commodity producers in Hedging and Investment Solutions. Intense competition could pressure margins, limit growth opportunities, or lead to a loss of market share.

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

## Expected Drivers of Future Revenue Growth for Marex (MRX) Marex (MRX) is poised for continued revenue growth over the next 2-3 years, driven by several strategic initiatives and favorable market conditions. Here are 3-5 expected drivers of Marex's future revenue growth: * Growth in Client Base, Especially Larger Clients, and Deepening Client Relationships: Marex has a strong track record of expanding its active client base and is focused on deepening relationships with existing clients. In 2025, the company saw a 36% increase in its largest clients (those generating over $5 million in annual revenue), with revenue from this segment growing over 80%. This indicates a successful strategy in attracting and retaining high-value clients, which is expected to continue contributing significantly to revenue growth. Marex aims to strengthen client relationships and enhance its offerings in the Americas. * Geographic Expansion and Broadening Market Access: Marex is actively expanding its global footprint, particularly in regions like the Middle East and APAC. A key initiative in its expansion strategy is the recent launch of its structured products business in the United States, targeting registered investment advisors, broker-dealers, and private banks. This move aims to diversify product offerings and leverage existing operating infrastructure in a market predominantly dominated by bank issuers, thereby tapping into new revenue streams across the Americas. Marex is also prioritizing growth in North America's energy and fixed income clearing markets. * Strategic Acquisitions to Enhance Capabilities and Market Reach: Marex has a consistent strategy of supplementing organic growth with strategic acquisitions. Acquisitions are a core component of Marex's growth strategy, with M&A contributing around 40% of growth in any given year. Recent examples include the acquisition of TD Cowen's prime services business in December 2023, Aarna Capital in March 2025, and the completed acquisition of UK equity market maker Winterflood Securities. These acquisitions are aimed at adding specific capabilities, expanding client bases, and enhancing service offerings, thereby bolstering overall revenue. Marex is continuing to build a robust acquisition pipeline. * Expansion and Innovation of Product and Service Offerings: Marex is continuously expanding its product and service offerings, driven by technological advancements and market demand. The launch of its structured products business in the U.S. is a prime example of broadening product capabilities. The company's focus on developing Prime Services, including its securities-based swaps offering, has been a notable contributor to net trading income growth. Marex's modern technology enables it to design products more nimbly and offer bespoke hedging and investment solutions, which helps meet evolving client needs and differentiates it from competitors.

AI Analysis | Feedback

Capital Allocation Decisions

Outbound Investments

Marex's strong cash flow supports opportunistic acquisition activity.
A significant portion of the uplift in return on equity in 2022 was driven by the acquisition of ED&F Man Capital Markets.
The company has a track record of organic growth supplemented by complementary acquisitions that are carefully and efficiently integrated into its infrastructure.

Capital Expenditures

Marex invests in its well-invested and industry-leading technology and support infrastructure to underpin growth and provide centralized back-office functions.
The company continues to invest in control and support functions, including technology, to reflect the scale of its global operations and ensure sustainable growth.

Interactive Breakdown

null

null

Better Bets vs. Marex (MRX)

null

Peer Outperformance in Diversified Capital Markets

null

Share of Diversified Capital Markets constituents that MRX has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.

—

insufficient peer history

—

insufficient peer history

—

insufficient peer history

null

Median price return by industry across the Financials sector, ranked by 5Y. Diversified Capital Markets is MRX's own industry. Use this to see which corners of the sector have carried the returns.

Industry	Names	1Y med	3Y med	5Y med	Top 3 by 5Y
Reinsurance	6	25.6%	72.3%	130.3%	SPNT 162% · RGA 145% · RNR 137%
Investment Banking & Brokerage	13	-0.7%	98.4%	114.1%	IBKR 490% · SNEX 242% · GS 174%
Diversified Banks	12	29.7%	123.6%	112.7%	CM 152% · JPM 151% · RY 143%
Life & Health Insurance	20	9.0%	54.4%	104.7%	JXN 546% · UNM 358% · FG 212%
Multi-Sector Holdings	4	3.5%	45.9%	80.7%	JONE 361% · BRK-B 84% · VOYA 77%
Property & Casualty Insurance	42	11.0%	67.5%	66.8%	ASIC 2816900% · HRTG 488% · UVE 321%
Regional Banks	265	25.6%	88.8%	64.1%	ESQ 371% · VBNK 348% · GCBC 328%
Multi-line Insurance	9	12.2%	71.6%	62.2%	GNW 191% · L 108% · SLF 97%
Financial Exchanges & Data	15	-9.0%	11.9%	30.6%	VIRT 182% · CBOE 130% · CME 77%
Diversified Financial Services	4	-11.2%	18.3%	26.4%	FRHC 168% · EQH 110% · TMS -58%
Consumer Finance	30	2.8%	81.9%	25.4%	ENVA 459% · EZPW 347% · FCFS 163%
Insurance Brokers	16	-16.5%	-6.4%	19.7%	LIFE 253% · ARX 89% · AJG 71%
Asset Management & Custody Banks	84	-10.6%	13.4%	11.6%	WT 303% · SII 270% · VCTR 247%
Commercial & Residential Mortgage Finance	13	-52.3%	20.7%	10.1%	FNMA 458% · FMCC 424% · ACT 204%
Specialized Finance	3	17.1%	37.2%	-1.0%	EFC 28% · CACC -1% · HASI -17%
Mortgage REITs	33	-11.8%	4.3%	-15.7%	NREF 53% · RITM 43% · DX 35%
Transaction & Payment Processing Services	15	-0.7%	-9.1%	-44.6%	V 73% · MA 70% · CPAY 57%
Diversified Capital Markets ←	20	-33.8%	14.9%	-57.1%	OPY 188% · LPLA 130% · GOLD 96%

Median of constituents with a full price history over each window. Top names are unfiltered by size in this render.

Latest Trefis Analyses

	Title	Date
0	DASHBOARDS
1	Marex Stock Rockets 26% With 7-Day Winning Streak	04/01/2026
2	Marex Stock Surges 23%, With A 6-Day Winning Spree	03/31/2026
3	Marex (MRX) Operating Cash Flow Comparison	02/17/2025
4	Marex (MRX) Net Income Comparison	02/16/2025
5	Marex (MRX) Operating Income Comparison	02/15/2025
6	Marex (MRX) Revenue Comparison	02/13/2025
7	ARTICLES
8	Small Cap Stocks Trading At 52-Week High	04/10/2026

	Title
0	DASHBOARDS
1	Marex Stock Rockets 26% With 7-Day Winning Streak
2	Marex Stock Surges 23%, With A 6-Day Winning Spree
3	Marex (MRX) Operating Cash Flow Comparison
4	Marex (MRX) Net Income Comparison
5	Marex (MRX) Operating Income Comparison
6	Marex (MRX) Revenue Comparison
7	ARTICLES
8	Small Cap Stocks Trading At 52-Week High

Trade Ideas

Select ideas related to MRX.

null

Recent Active Movers

Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
SDGR	Schrodinger	2.3	26.4%	69.1%
ADBT	Advasa	0.1	19.6%	-97.7%
GNRC	Generac	12.2	18.3%	52.0%
VICR	Vicor	9.9	17.7%	97.4%
CRD-B	Crawford	0.6	16.0%	24.8%
ABSI	Absci	1.5	15.3%	165.6%
SECZ	Securitize	1.3	14.9%	-27.4%
TEM	Tempus AI	14.5	14.8%	36.1%
FCEL	FuelCell Energy	1.0	14.3%	142.3%
PSIX	Power Solutions International	1.0	13.6%	-20.3%

Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
FLNC	Fluence Energy	1.1	-15.4%	-61.3%
AN	AutoNation	5.9	-10.5%	-15.3%
SAH	Sonic Automotive	2.1	-9.3%	8.4%
ASTH	Astrana Health	1.7	-9.0%	38.3%
MAMA	Mama's Creations	0.5	-8.0%	-2.8%
MTZ	MasTec	16.2	-7.9%	-4.4%
DKNG	DraftKings	11.1	-7.6%	-34.8%
ANGX	Angel Studios	0.9	-7.5%	4.9%
XRAY	Dentsply Sirona	1.9	-7.5%	-18.0%
TTAN	ServiceTitan	5.2	-7.5%	-49.1%

Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
SDGR	Schrodinger	2.3	60.9%	69.1%
ACVA	ACV Auctions	1.8	45.2%	30.7%
TEM	Tempus AI	14.5	36.8%	36.1%
FEIM	Frequency Electronics	0.8	35.1%	55.7%
EMAT	Evolution Metals & Technologies	2.5	30.5%	-81.1%
FPS	Forgent Power Solutions	9.3	30.3%	31.2%
BBNX	Beta Bionics	1.0	29.2%	-29.7%
CAI	Caris Life Sciences	8.7	28.6%	14.6%
RXT	Rackspace Technology	1.0	25.2%	303.7%
WGS	GeneDx	3.1	25.0%	-19.3%

Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
ADBT	Advasa	0.1	-53.9%	-97.7%
SWMR	Swarmer	0.4	-33.2%	-22.5%
ALHC	Alignment Healthcare	1.8	-31.8%	-55.9%
ALMS	Alumis	1.0	-21.0%	-19.9%
FLNC	Fluence Energy	1.1	-20.9%	-61.3%
ENVA	Enova International	4.5	-19.7%	13.9%
ARWR	Arrowhead Pharmaceuticals	9.7	-18.1%	2.0%
SPRY	ARS Pharmaceuticals	0.4	-18.0%	-64.4%
MPLT	MapLight Therapeutics	0.5	-17.9%	-35.6%
ASMB	Assembly Biosciences	0.5	-16.8%	-25.5%

Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
MRNA	Moderna	62.9	151.1%	436.0%
PURR	Hyperliquid Strategies	1.6	78.2%	260.4%
SDGR	Schrodinger	2.3	71.1%	69.1%
TEM	Tempus AI	14.5	62.8%	36.1%
SECZ	Securitize	1.3	51.6%	-27.4%
CVI	CVR Energy	5.4	47.7%	114.1%
CAI	Caris Life Sciences	8.7	47.4%	14.6%
MSTR	Strategy	46.6	42.9%	-13.0%
IOVA	Iovance Biotherapeutics	4.5	42.5%	267.0%
TXG	10x Genomics	10.0	38.4%	371.9%

Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
ALMS	Alumis	1.0	-68.6%	-19.9%
SWMR	Swarmer	0.4	-48.7%	-22.5%
IESC	IES	12.6	-48.3%	-18.5%
RARE	Ultragenyx Pharmaceutical	1.5	-43.1%	-37.0%
KRMN	Karman	4.7	-40.7%	-51.8%
TTAN	ServiceTitan	5.2	-40.5%	-49.1%
ALOY	REalloys	0.5	-38.9%	-12.6%
IMUX	Immunic	0.4	-38.8%	93.9%
FLNC	Fluence Energy	1.1	-34.8%	-61.3%
DKS	Dick's Sporting Goods	11.0	-34.7%	-36.0%

Peer Comparisons

Peers to compare with:

Financials

	MRX	IOND	PWCM	VIP	LPLA	CRCL	Median
Name	Marex	Ionic Di.	PowerCom.	Vulcan I.	LPL Fina.	Circle I.
Mkt Price	73.27	84.85	0.92	1.85	329.94	85.09	79.06
Mkt Cap	5.3	-	-	-	26.3	21.1	21.1
Rev LTM	5,172	178	9	51	19,610	2,905	1,542
Op Inc LTM	1,756	23	-28	-23	1,777	215	119
FCF LTM	-	-107	-40	-20	-931	710	-40
FCF 3Y Avg	-	-	-21	-24	-275	415	-22
CFO LTM	-	-97	-15	-20	-252	777	-20
CFO 3Y Avg	-	-	-12	-17	291	463	140

Growth & Margins

	MRX	IOND	PWCM	VIP	LPLA	CRCL	Median
Name	Marex	Ionic Di.	PowerCom.	Vulcan I.	LPL Fina.	Circle I.
Rev Chg LTM	48.9%	-	16.3%	-14.1%	38.8%	37.2%	37.2%
Rev Chg 3Y Avg	-	-	101.5%	-8.4%	28.2%	384.3%	64.8%
Rev Chg Q	135.3%	17.0%	9.8%	-73.7%	35.2%	6.6%	13.4%
QoQ Delta Rev Chg LTM	15.0%	4.1%	2.2%	-15.7%	7.4%	1.5%	3.2%
Op Inc Chg LTM	69.2%	-	-283.1%	-50.1%	-2.1%	230.4%	-2.1%
Op Inc Chg 3Y Avg	-	-	-	5.6%	1.9%	-120.2%	1.9%
Op Mgn LTM	33.9%	13.0%	-321.5%	-45.2%	9.1%	7.4%	8.2%
Op Mgn 3Y Avg	-	-	-	-30.1%	12.0%	0.8%	0.8%
QoQ Delta Op Mgn LTM	1.9%	20.4%	-44.0%	-14.6%	0.1%	12.5%	1.0%
CFO/Rev LTM	-	-54.5%	-176.7%	-39.7%	-1.3%	26.7%	-39.7%
CFO/Rev 3Y Avg	-	-	-124.8%	-29.6%	2.6%	20.3%	-13.5%
FCF/Rev LTM	-	-60.1%	-460.3%	-40.1%	-4.7%	24.4%	-40.1%
FCF/Rev 3Y Avg	-	-	-228.0%	-39.3%	-1.3%	17.8%	-20.3%

Valuation

	MRX	IOND	PWCM	VIP	LPLA	CRCL	Median
Name	Marex	Ionic Di.	PowerCom.	Vulcan I.	LPL Fina.	Circle I.
Mkt Cap	5.3	-	-	-	26.3	21.1	21.1
P/S	1.0	-	-	-	1.3	7.3	1.3
P/Op Inc	3.0	-	-	-	14.8	98.0	14.8
P/EBIT	3.0	-	-	-	14.8	52.4	14.8
P/E	12.4	-	-	-	26.1	46.8	26.1
P/CFO	-	-	-	-	-104.4	27.2	-38.6
Total Yield	8.1%	-	-	-	4.2%	2.1%	4.2%
Dividend Yield	0.0%	-	-	-	0.4%	0.0%	0.0%
FCF Yield 3Y Avg	-	-	-	-	-1.2%	-	-1.2%
D/E	2.2	-	-	-	0.3	0.0	0.3
Net D/E	0.6	-	-	-	0.2	-0.1	0.2

Returns

	MRX	IOND	PWCM	VIP	LPLA	CRCL	Median
Name	Marex	Ionic Di.	PowerCom.	Vulcan I.	LPL Fina.	Circle I.
1M Rtn	2.2%	29.5%	-32.2%	3.4%	-10.5%	18.6%	2.8%
3M Rtn	12.6%	34.9%	-58.1%	-24.5%	12.3%	6.1%	9.2%
6M Rtn	12.6%	34.9%	-58.1%	-24.5%	15.8%	-33.7%	-6.0%
12M Rtn	12.6%	34.9%	-58.1%	-24.5%	-1.5%	-35.1%	-13.0%
3Y Rtn	12.6%	34.9%	-58.1%	-24.5%	35.5%	2.2%	7.4%
1M Excs Rtn	2.9%	30.2%	-31.5%	4.1%	-9.8%	19.3%	3.5%
3M Excs Rtn	9.7%	32.0%	-61.0%	-27.4%	5.5%	2.7%	4.1%
6M Excs Rtn	-2.7%	19.6%	-73.4%	-39.8%	-0.6%	-51.2%	-21.2%
12M Excs Rtn	-3.0%	19.3%	-73.7%	-40.1%	-17.1%	-52.5%	-28.6%
3Y Excs Rtn	-58.6%	-36.3%	-129.3%	-95.7%	-33.6%	-68.9%	-63.8%

FDIC Bank Data

Bank Capital

null

Bank Deposits

null

Bank Assets

null

Bank Loans

null

FDA Approved Drugs Data

Expand for Morenull

Clinical Pipeline

null

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2025	2024	2023	2022	2021
Period End	6/30/2026	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Filing Date	8/12/2026	3/25/2026	3/21/2025	4/26/2024	3/21/2025	4/26/2024
Key Financials
Total Revenue	5,172	3,630	2,895	2,352	1,175	852
Net Income	426	307	218	141	98	56
EPS	5.77	4.12	2.96	1.81	1.29	0.80
Growth Rates
Total Revenue Growth	48.9%	25.4%	23.1%	100.1%	38.0%	-
Net Income Growth	61.2%	40.9%	54.3%	43.9%	73.8%	-
Margins
Net Income Margin	8.2%	8.5%	7.5%	6.0%	8.4%	6.6%
Cash & Debt
Total Cash	8,372	6,465	5,126	4,656	3,221	758
Total Debt	11,529	10,235	6,140	5,388	5,729	1,290
Net Debt / (Cash)	3,157	3,770	1,014	732	2,508	532
Cash Flows & CapEx
Net Cash from Operations	-	668	1,164	735	226	471
Total CapEx	0	-20	-20	-12	-9	-7
Free Cash from Operations	-	648	1,144	723	216	464
Returns to Shareholders
Dividends	0	56	77	58	7	20
Share Repurchases	-0	44	20	3	8	-0

$ Mil \| FY: 12/31	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3
Period End	6/30/2026	3/31/2026	12/31/2025	9/30/2025	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023
Filing Date	8/12/2026	5/6/2026	3/25/2026	11/6/2025	8/13/2025	5/15/2025	3/21/2025	11/7/2024	8/14/2024	5/16/2024	4/26/2024	11/7/2024
Key Financials Quarterly
Total Revenue	1,176	1,333	2,178	485	500	866	1,716	391	422	675	1,433	297
Net Income	156	112	85	73	77	72	57	58	59	44	28	32
EPS	2.09	1.52	1.19	0.97	1.03	0.98	0.76	0.78	0.81	0.62	0.21	0.46
Key Financials TTM
Total Revenue TTM	5,172	4,496	4,028	3,566	3,473	3,395	3,204	2,922	2,827	3,039	2,941	-
Net Income TTM	426	347	307	279	264	247	218	189	163	167	141	-
Growth Rates Quarterly
Total Revenue Growth	135.3%	54.0%	26.9%	23.9%	18.5%	28.2%	19.7%	31.9%	-33.4%	17.0%	-	-
Net Income Growth	102.9%	55.0%	49.6%	25.3%	29.3%	66.3%	101.8%	80.2%	-5.4%	140.9%	-	-
Margins Quarterly
Net Income Margin	13.2%	8.4%	3.9%	15.1%	15.3%	8.4%	3.3%	14.9%	14.0%	6.5%	2.0%	10.9%
Cash & Debt
Total Cash	8,372	6,877	6,465	7,347	6,909	5,207	5,126	5,829	4,447	-	4,656	-
Total Debt	11,529	10,363	10,235	8,791	8,548	6,813	6,140	4,969	4,369	0	5,388	0
Net Debt / (Cash)	3,157	3,486	3,770	1,445	1,640	1,606	1,014	-860	-78	-	732	-
Cash Flows Quarterly
FCF from Operations	-	-	-	-	-	-	-	-	-	-	-	-
Cash Flows TTM
FCF from Operations TTM	-	-	-	-	-	-	-	-	-	-	-	-
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	33.5%	29.4%	67.9%	16.8%	10.9%	38.7%	145.2%	230.5%	138.7%	-	16.7%	-
Return on Invested Capital (ROIC) TTM
ROIC TTM	35.2%	29.2%	24.7%	46.6%	27.8%	41.0%	57.0%	259.2%	132.8%	-	20.9%	-

Segment Financials

Revenue by Segment

$ Mil	2025	2024	2023	2022	2021
Agency and Execution	1,049	695	542	231	192
Clearing	528	466	374	200	120
Market Making	236	208	154	173	141
Hedging and Investments solutions	197	162	128	100	89
Corporate	14	64	48	8	0
Total	2,024	1,595	1,245	711	542

Price Behavior

null

MRX Betas & Captures as of 8/31/2026

	1M	2M	3M	6M	1Y	3Y
Beta	0.45	1.55	-1.29	-1.09	-1.90	-0.87
Up Beta	-3.31	0.02	-1.55	-0.99	0.28	0.07
Down Beta	-1.20	1.77	-0.80	0.83	0.40	-0.91
Up Capture	312%	242%	141%	53%	24%	2%
Bmk +ve Days	10	21	32	68	138	427
Stock +ve Days	10	19	19	19	19	19
Down Capture	196%	172%	91%	53%	33%	18%
Bmk -ve Days	11	21	32	59	113	324
Stock -ve Days	11	23	23	23	23	23

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Based On 1-Year Data

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with MRX
MRX	12.6%	60.0%	1.12	-
Sector ETF (XLF)	5.6%	14.6%	0.15	11.6%
Equity (SPY)	16.6%	12.9%	0.92	28.2%
Gold (GLD)	17.4%	29.3%	0.55	11.7%
Commodities (DBC)	45.8%	20.7%	1.72	-9.2%
Real Estate (VNQ)	5.7%	13.5%	0.16	3.6%
Bitcoin (BTCUSD)	-34.9%	43.9%	-0.85	17.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with MRX
MRX	2.4%	60.0%	1.12	-
Sector ETF (XLF)	9.9%	18.4%	0.40	11.6%
Equity (SPY)	12.6%	17.2%	0.56	28.2%
Gold (GLD)	18.9%	18.8%	0.81	11.7%
Commodities (DBC)	11.7%	19.6%	0.47	-9.2%
Real Estate (VNQ)	1.0%	18.8%	-0.05	3.6%
Bitcoin (BTCUSD)	10.4%	52.5%	0.38	17.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 10-Year Data

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with MRX
MRX	1.2%	60.0%	1.12	-
Sector ETF (XLF)	12.9%	22.1%	0.53	11.6%
Equity (SPY)	15.1%	18.0%	0.71	28.2%
Gold (GLD)	12.0%	16.4%	0.60	11.7%
Commodities (DBC)	8.5%	18.1%	0.39	-9.2%
Real Estate (VNQ)	4.4%	20.7%	0.17	3.6%
Bitcoin (BTCUSD)	62.0%	66.1%	1.02	17.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date	8312026
Short Interest: Shares Quantity	2.6 Mil
Short Interest: % Change Since 8152026	-12.2%
Average Daily Volume	0.5 Mil
Days-to-Cover Short Interest	4.8 days
Basic Shares Quantity	72.1 Mil
Short % of Basic Shares	3.5%

Returns Analyses

null

Earnings Returns History

Updated 6/2/2026

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
SUMMARY STATS
# Positive	0	0	0
# Negative	0	0	0
Median Positive
Median Negative
Max Positive
Max Negative

Collapse to Preview

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
SUMMARY STATS
# Positive	0	0	0
# Negative	0	0	0
Median Positive
Median Negative
Max Positive
Max Negative

SEC Filings

Expand for More

Report Date	Filing Date	Filing
06/30/2026	08/12/2026	6-K
03/31/2026	05/06/2026	6-K
12/31/2025	03/25/2026	20-F
09/30/2025	11/06/2025	6-K
06/30/2025	08/13/2025	6-K
03/31/2025	05/15/2025	6-K
12/31/2024	03/21/2025	20-F
09/30/2024	11/07/2024	6-K
06/30/2024	08/14/2024	6-K
03/31/2024	05/16/2024	6-K
12/31/2023	04/26/2024	424B4

Collapse to Preview

Report Date	Filing Date	Filing
06/30/2026	08/12/2026	6-K
03/31/2026	05/06/2026	6-K
12/31/2025	03/25/2026	20-F
09/30/2025	11/06/2025	6-K
06/30/2025	08/13/2025	6-K
03/31/2025	05/15/2025	6-K
12/31/2024	03/21/2025	20-F
09/30/2024	11/07/2024	6-K
06/30/2024	08/14/2024	6-K
03/31/2024	05/16/2024	6-K
12/31/2023	04/26/2024	424B4

Recent Forward Guidance

Updated 9/17/2026

Latest: null Earnings Reported N/A/N/A/N/A

null

Insider Activity

Updated 9/16/2026

Expand for More

#	Owner	Title	Holding	Action	Filing Date	Price	Shares	Transacted Value	Value of Held Shares	Form
1	Tonucci, Paolo	See Remarks	Direct	Sell	9162026	70.87	16,666	1,181,167	89,978,121	Form
2	Van, Den Born Simon	President	Direct	Sell	9162026	70.87	15,271	1,082,277	104,205,632	Form
3	Irvin, Rob	Chief Financial Officer	Direct	Sell	8182026	70.96	3,700	262,545	2,202,969	Form
4	Tonucci, Paolo	See Remarks	Direct	Sell	8122026	60.92	16,668	1,015,347	77,095,791	Form
5	Tonucci, Paolo	See Remarks	Direct	Sell	7152026	64.42	16,666	1,073,578	82,600,759	Form

Collapse to Preview

#	Owner	Title	Holding	Action	Filing Date	Price	Shares	Transacted Value	Value of Held Shares	Form
1	Tonucci, Paolo	See Remarks	Direct	Sell	9162026	70.87	16,666	1,181,167	89,978,121	Form
2	Van, Den Born Simon	President	Direct	Sell	9162026	70.87	15,271	1,082,277	104,205,632	Form
3	Irvin, Rob	Chief Financial Officer	Direct	Sell	8182026	70.96	3,700	262,545	2,202,969	Form
4	Tonucci, Paolo	See Remarks	Direct	Sell	8122026	60.92	16,668	1,015,347	77,095,791	Form
5	Tonucci, Paolo	See Remarks	Direct	Sell	7152026	64.42	16,666	1,073,578	82,600,759	Form
6	Lowitt, Ian T	Chief Executive Officer	Direct	Sell	7152026	64.39	37,142	2,391,703	179,929,321	Form
7	Tonucci, Paolo	See Remarks	Direct	Sell	6162026	62.45	16,666	1,040,849	81,123,458	Form
8	Lowitt, Ian T	Chief Executive Officer	Direct	Sell	6162026	62.37	37,143	2,316,498	176,583,309	Form
9	Texier, Thomas	Group Head of Clearing	Direct	Sell	6032026	53.35	1,572	83,865	11,044,364	Form
10	Tonucci, Paolo	See Remarks	Direct	Sell	5132026	55.92	16,668	932,136	75,311,836	Form
11	Texier, Thomas	Group Head of Clearing	Direct	Sell	5052026	52.99	14,427	764,487	12,093,972	Form
12	Van, Den Born Simon	President	Direct	Sell	4222026	50.95	13,265	675,916	76,889,011	Form
13	Tonucci, Paolo	See Remarks	Direct	Sell	4152026	51.37	16,666	856,049	70,028,835	Form
14	Van, Den Born Simon	President	Direct	Sell	4022026	43.51	13,264	577,105	66,230,837	Form
15	Texier, Thomas	Group Head of Clearing	Direct	Sell	4022026	43.51	14,427	627,715	10,557,994	Form

Investor Activity (13F)

Updated Sep 18, 2026

13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active Manager	Value	% of Portfolio	Total Positions	QoQ	Filing
Grandeur Peak Global Advisors, LLC	$59.1 Mil	13.8%	86	TRIM -25.5%	13F
Praetorian PR LLC	$22.3 Mil	8.1%	12	Hold	13F
Ophir Asset Management Pty Ltd	$55.6 Mil	6.5%	34	ADD +14.7%	13F
Deltroit Asset Management (UK) LLP	$20.1 Mil	3.5%	39	TRIM -5.3%	13F
Engle Capital Management, L.P.	$9.0 Mil	3.1%	22	ADD +5.3%	13F

Active Manager	Value	% of Portfolio	Total Positions	QoQ	Filing
Ophir Asset Management Pty Ltd	$55.6 Mil	6.5%	34	ADD +14.7%	13F
Engle Capital Management, L.P.	$9.0 Mil	3.1%	22	ADD +5.3%	13F

Active Manager	Value	% of Portfolio	Total Positions	QoQ	Filing
Grandeur Peak Global Advisors, LLC	$59.1 Mil	13.8%	86	TRIM -25.5%	13F
Deltroit Asset Management (UK) LLP	$20.1 Mil	3.5%	39	TRIM -5.3%	13F

Active Manager	Value	% of Portfolio	Total Positions	QoQ	Filing
Grandeur Peak Global Advisors, LLC	$59.1 Mil	13.8%	86	TRIM -25.5%	13F
Ophir Asset Management Pty Ltd	$55.6 Mil	6.5%	34	ADD +14.7%	13F
Praetorian PR LLC	$22.3 Mil	8.1%	12	Hold	13F
Deltroit Asset Management (UK) LLP	$20.1 Mil	3.5%	39	TRIM -5.3%	13F
Engle Capital Management, L.P.	$9.0 Mil	3.1%	22	ADD +5.3%	13F

MRX Trade Sentinel

Stock Conviction

null

CONVICTION RATIONALE

null

STOCK ARCHETYPE

null

Looking for high-conviction positions with a better risk/reward profile? See what's currently in the Trefis High Quality Portfolio.

INVESTMENT THESIS

null

Mechanism: null

Supporting Evidence:

PRIMARY RISK

null

Mechanism: null

Supporting Evidence:

Key KPI Watchlist

KPI	Status	Rationale

Core Investment Debate

BULL VIEW

CORE TENSION

PREVAILING SENTIMENT

BEAR VIEW

Next 6 months: Risks and Catalysts

Timeline	Event & Metric To Watch

Key Events in Last 6 Months

Date	Event	Stock Impact

Risk Management

Position Sizing

Diversification Alternatives

How Is The Market Pricing MRX?

What will confirm the thesis

What will damage the thesis

Noise: Real but irrelevant to thesis

Repricing Catalyst

What MRX Makes & Who Pays

TTM figures based on

MRX Evolution: Price Return by Era

① Structure

② Volume / Momentum

③ Catalyst

Combined Score

0 / 12

1 Price Structure & Trend · ▾

2 Momentum ▾

3 Relative Strength vs. SPY ▾

4 Institutional Footprint & Volume ▾

5 Volatility ▾

6 Key Price Levels Range · Vol ▾

7 Earnings Reaction History ▾

8 How the Verdict Is Derived Three Pillars ▾

Pillar	Score
① Structure	0
② Vol / Mom	0
③ Catalyst	0

ℹ Bull Pillars: 0 · Bear Pillars: 0 · Combined Score: 0 →

Marex — Investor Video Playlist

Leadership

The formula for M&A success: how Marex scales with purpose | Suite Talk

Marex Group · 2026-09-16

Products & Services

Navigating a new era of FX risk | The Marex Market Pulse podcast

Marex Group · 2026-08-26

Products & Services

Ai, institutional adoption and what's next for crypto | The Marex Market Pulse podcast

Marex Group · 2026-08-07

Products & Services

SpaceX's IPO and the Future of Investing — Winterflood | The Marex Market Pulse Podcast

Marex Group · 2026-07-24

Products & Services

What’s driving the next phase of US power markets? | The Marex Market Pulse podcast

Marex Group · 2026-07-02

Products & Services

Structured products: AI, volatility and investor demand | The Marex Market Pulse podcast

Marex Group · 2026-07-02

Products & Services

Inside precious metals: ME tensions, ETF flows, safe-haven demand | The Marex Market Pulse podcast

Marex Group · 2026-06-22

Investor / Analyst

Marex Investor Day 2026

Marex Group · 2026-06-11

Products & Services

Inside the CORSIA market: supply, risk and the road to compliance | The Marex Market Pulse Podcast

Marex Group · 2026-06-11

Products & Services

About Marex

Marex Group · 2026-06-11

Industry Resources

Financials Resources

Federal Reserve Economic Data

Diversified Capital Markets Resources

International Financing Review (IFR)

Financial News

Global Capital

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Core Cache Last Updated: 9/17/2026

Marex (MRX)

Market Price (9/18/2026): $73.26 | Market Cap: $5.3 BilSector: Financials | Industry: Diversified Capital Markets

Marex (MRX)

Market Price (9/18/2026): $73.26Market Cap: $5.3 BilSector: FinancialsIndustry: Diversified Capital Markets

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

MRX in ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

In The Past

Preserve Wealth

Asset Allocation

About Marex (MRX)

Capital Allocation Decisions

Outbound Investments

Capital Expenditures

Interactive Breakdown

Better Bets vs. Marex (MRX)

Peer Outperformance in Diversified Capital Markets

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

Top Gainers

Top Losers

Top Gainers

Top Losers

Top Gainers

Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

FDA Approved Drugs Data

Clinical Pipeline

Financials

Segment Financials

Price Behavior

Based On 1-Year Data

Based On 5-Year Data

Based On 10-Year Data

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Recent Forward Guidance

Insider Activity

Investor Activity (13F)

MRX Trade Sentinel

null

CONVICTION RATIONALE

STOCK ARCHETYPE

INVESTMENT THESIS

PRIMARY RISK

Market Price (9/18/2026): $73.26
Market Cap: $5.3 Bil
Sector: Financials
Industry: Diversified Capital Markets